First Time Loading...

Graphite Bio Inc
NASDAQ:GRPH

Watchlist Manager
Graphite Bio Inc Logo
Graphite Bio Inc
NASDAQ:GRPH
Watchlist
Price: 50 USD Market Closed
Updated: Apr 27, 2024
Section:
 

Wall Street
Price Targets

GRPH Price Targets Summary
Graphite Bio Inc

Wall Street analysts forecast GRPH stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GRPH is 7 USD .

GRPH Lowest Forecast
Wall Street Target
Not Available
GRPH Average Forecast
Wall Street Target
7 USD
86% Downside
GRPH Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
7 USD
86% Downside
Highest
Price Target
Not Available

GRPH Last Price Targets
Graphite Bio Inc

The latest public price target was made on Feb 3, 2023 by Unknown Analyst from Morgan Stanley , who expects GRPH stock to drop by 94% over the next 12 months. You can read more about this price target by viewing the article on Benzinga.

Analyst Price Target Date Article
Unknown Analyst
Morgan Stanley
3 USD
Downside 94%
1 year ago
Feb 3, 2023
Morgan Stanley Maintains Equal-Weight on Graphite Bio, Lowers Price Target to $3
Benzinga
Unknown Analyst
Morgan Stanley
Price Target 3 USD
Upside/Downside 94%
View Source
Graphite Bio Inc Competitors:
Price Targets
MRUS
Merus NV
38% Upside
EXEL
Exelixis Inc
15% Upside
X
688278
Xiamen Amoytop Biotech Co Ltd
18% Downside
002007
Hualan Biological Engineering Inc
40% Upside
MRUS
Merus NV
38% Upside
EXEL
Exelixis Inc
15% Upside
X
688278
Xiamen Amoytop Biotech Co Ltd
18% Downside
002007
Hualan Biological Engineering Inc
40% Upside
PHIL
Philogen SpA
30% Upside
L
2157
Lepu Biopharma Co Ltd
25% Downside
PYC
PYC Therapeutics Ltd
278% Upside
2INV
2Invest AG
72% Downside

Revenue
Forecast

Revenue Estimate
Graphite Bio Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Graphite Bio Inc

Operating Income forecast
is not available for
Graphite Bio Inc

Net Income
Forecast

Net Income Estimate
Graphite Bio Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss
What are analyst estimates?

See Also

Summary
GRPH intrinsic value, competitors valuation, and company profile.
DCF Valuation
GRPH stock valuation using Discount Cash Flow valuation method.
Relative Valuation
GRPH stock valuation using valuation multiples.
Wall Street Estimates
GRPH price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
GRPH stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GRPH's stock price target?
Price Target
7 USD

According to Wall Street analysts, the average 1-year price target for GRPH is 7 USD .

ALPHA SPREAD
Join more than 131,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.